SEC Form 3 · accession 0001209191-15-034127
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Judice
Director
Period of report
Apr 14, 2015
Accepted (ET)
Apr 14, 2015 · 7:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 94,488 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.29 | holding | — | — | — | Sep 9, 2014 | Sep 8, 2024 | Common Stock | 92,065 | — | D |
Explanation of responses
- F1The option is immediately exercisable, with vesting as follows: 25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of July 1, 2014; 1/48th of the shares subject to the option shall vest monthly thereafter, such that all shares will be vested on July 1, 2018.